Dr. Reddy’s Lab gains on launching skin care product

Dr. Reddys Laboratories is currently trading at Rs. 2311.45, up by 28.30 points or 1.24 % from its previous closing of Rs. 2283.15 on the BSE. The scrip opened at Rs. 2300.00 and has touched a high and low of Rs. 2315.20 and Rs. 2266.00 respectively. So far 6406 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2939.80 on 28-Feb-2014 and a 52 week low of Rs. 2012.00 on 21-May-2013. Last one week high and low of the scrip stood at Rs. 2743.05 and Rs. 2250.00 respectively. The current market cap of the company is Rs. 38838.41 crore.  The promoters holding in the company stood at 25.52 % while Institutions and Non-Institutions held 40.59 % and 15.87 % respectively. Dr Reddy’s Laboratories has unveiled daily moisturiser cream Rebask in the domestic market. The cream is an advanced ceramide dominant, non-greasy and quick absorbing formulation that helps in moisturisation of skin. It also forms a skin barrier that prevents loss of moisture through the skin. Skin barrier is a natural layer, offering protection against moisture loss through the skin surface that gets damaged in conditions such as atopic dermatitis and psoriasis. Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.